ReportsnReports Adds,The global market for chromatography resin in drug discovery is projected to grow from USD 290.7 million in 2017 to USD 401.1 million by 2022, at a CAGR of 6.65% from 2017 to 2022. The ion exchange segment is expected to account for the largest share of the chromatography resin market in drug discovery, in terms of volume.
Browse Sample Papers of “Chromatography Resin Market “spread across 142 Pages, Profiling 10 Companies and Supported with 103 Tables and 58 Figures is now available at: www.reportsnreports.com/contacts/r….aspx?name=271302
Various companies supplying chromatography resin and related products are as follows:
- Bio-Rad Laboratories Inc. (U.S.)
- GE Healthcare (U.S.)
- Tosoh Corporation (Japan)
- Merck KGaA (U.S.)
- Pall Corporation (U.S.)
- Sepragen Corporation (U.S.)
- Knauer Wissenschaftliche Geräte GmbH (Germany)
- Kaneka Corporation (Japan)
- Purolite Corporation (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
Get Report @ www.reportsnreports.com/contacts/d….aspx?name=271302
“Increasing demand for therapeutic antibodies and increasing R&D in bio pharmaceuticals across the globe to drive the market for chromatography resin in drug discovery”
The global market for chromatography resin in drug discovery is projected to grow from USD 290.7 million in 2017 to USD 401.1 million by 2022, at a CAGR of 6.65% from 2017 to 2022. Factors such as the growing demand for therapeutic antibodies and rising R&D in bio pharmaceuticals are expected to drive the market.
The key constraint for the growth of this market is the lack of adequately skilled professionals.
“The ion exchange segment estimated to account for a major share during the forecast period”
The ion exchange segment is expected to account for the largest share of the chromatography resin market in drug discovery, in terms of volume.
This high share can be attributed to the increasing demand for this technique in the pharmaceutical industry owing to the increasing need for efficient separation methods.
“Synthetic polymer projected to be the fastest-growing segment in the chromatography resin market in drug discovery”
The synthetic polymer segment is projected to grow at the highest CAGR during the forecast period. The demand for synthetic polymers is expected to be driven by their use in ion exchange chromatography.
Polystyrene divinylbenzene is the most commonly used synthetic polymer, which is being increasingly used in ion exchange applications because of its better performance in comparison to natural polymer. Industrial-scale purification of bio pharmaceuticals and quantitative and qualitative analysis of drugs are the key application areas of chromatography resin.
Get Full Access of Research Report at:
“North America accounted for the largest market share in 2016”
The chromatography resin market in drug discovery is segmented based on region into North America, Europe, Asia-Pacific, and RoW. North America accounted for the largest share of the chromatography resin market in drug discovery in 2016.
This large share can be attributed to the continuous R&D activities in therapeutic monoclonal antibodies in oncology and other therapeutic areas in the region.
Breakdown of primaries:
Primary interviews were conducted with a number of industry experts to collect data related to different aspects of chromatography resin market in drug discovery. The distribution of primary interviews is as follows:
- By Company Type:Tier 1 - 46%, Tier 2 - 31%, and Tier 3 - 23%
- By Designation:Clevel - 46%, D level- 27%, and Others - 27%
- By Region:North America- 33%, Europe – 27%, Asia-Pacific- 27%, and Rest of the World- 13%
1 Attractive Opportunities in Chromatography Resin Market in Drug Discovery
2 Chromatography Resin Market, By Region
3 Affinity Chromatography Resin Market in North America
4 Chromatography Resin Market Attractiveness
5 Chromatography Resin Market, By Technique
6 Chromatography Resin Market in Drug Discovery: Developing vs Developed Countries
2 Market Segmentation
2.1 By Type
2.2 By Technique
2.3 By Region
3 Market Dynamics
3.1 Impact Analysis
3.2.1 Increasing Demand for Therapeutic Antibodies
3.2.2 Increasing R&D in Biopharmaceuticals
3.3.1 High Cost of Affinity Resin
3.3.2 Lack of Adequate Skilled Professionals
3.4.1 High Growth of Biopharmaceutical R&D Activity in Asia-Pacific
3.4.2 Growing Demand for Disposable Pre-Packed Columns
Need More Details Inquire at: